Np mrd loader

Record Information
Version1.0
Created at2021-01-05 21:39:59 UTC
Updated at2021-07-15 17:11:09 UTC
NP-MRD IDNP0012216
Secondary Accession NumbersNone
Natural Product Identification
Common NameJahnellamide B
Provided ByNPAtlasNPAtlas Logo
Description Jahnellamide B is found in Jahnella. It was first documented in 2012 (PMID: 34383397). Based on a literature review very few articles have been published on N-[(3S,7R,10Z,13R,17S,22aS)-1,8,11,14-tetrahydroxy-13-[2-(C-hydroxycarbonimidoyl)ethyl]-7-{2-[(2-hydroxyethyl)-C-hydroxycarbonimidoyl]ethyl}-10-[(1H-indol-3-yl)methylidene]-3-[2-(methylsulfanyl)ethyl]-4,5,18-trioxo-3H,4H,5H,6H,7H,10H,13H,16H,17H,18H,20H,21H,22H,22aH-pyrrolo[1,2-n]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzenecarboximidic acid (PMID: 24199909) (PMID: 34383398) (PMID: 34383396) (PMID: 34384147) (PMID: 34384146) (PMID: 34384145).
Structure
Thumb
Synonyms
ValueSource
N-[(3S,7R,10Z,13R,17S,22AS)-1,8,11,14-tetrahydroxy-13-[2-(C-hydroxycarbonimidoyl)ethyl]-7-{2-[(2-hydroxyethyl)-C-hydroxycarbonimidoyl]ethyl}-10-[(1H-indol-3-yl)methylidene]-3-[2-(methylsulfanyl)ethyl]-4,5,18-trioxo-3H,4H,5H,6H,7H,10H,13H,16H,17H,18H,20H,21H,22H,22ah-pyrrolo[1,2-N]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzenecarboximidateGenerator
N-[(3S,7R,10Z,13R,17S,22AS)-1,8,11,14-tetrahydroxy-13-[2-(C-hydroxycarbonimidoyl)ethyl]-7-{2-[(2-hydroxyethyl)-C-hydroxycarbonimidoyl]ethyl}-10-[(1H-indol-3-yl)methylidene]-3-[2-(methylsulphanyl)ethyl]-4,5,18-trioxo-3H,4H,5H,6H,7H,10H,13H,16H,17H,18H,20H,21H,22H,22ah-pyrrolo[1,2-N]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzenecarboximidateGenerator
N-[(3S,7R,10Z,13R,17S,22AS)-1,8,11,14-tetrahydroxy-13-[2-(C-hydroxycarbonimidoyl)ethyl]-7-{2-[(2-hydroxyethyl)-C-hydroxycarbonimidoyl]ethyl}-10-[(1H-indol-3-yl)methylidene]-3-[2-(methylsulphanyl)ethyl]-4,5,18-trioxo-3H,4H,5H,6H,7H,10H,13H,16H,17H,18H,20H,21H,22H,22ah-pyrrolo[1,2-N]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzenecarboximidic acidGenerator
Chemical FormulaC44H54N10O11S
Average Mass931.0400 Da
Monoisotopic Mass930.36942 Da
IUPAC NameN-[(3S,7R,10Z,17S,22aS)-13-(2-carbamoylethyl)-7-{2-[(2-hydroxyethyl)carbamoyl]ethyl}-10-[(1H-indol-3-yl)methylidene]-3-[2-(methylsulfanyl)ethyl]-1,4,5,8,11,14,18-heptaoxo-docosahydropyrrolo[1,2-n]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzamide
Traditional NameN-[(3S,7R,10Z,17S,22aS)-13-(2-carbamoylethyl)-7-{2-[(2-hydroxyethyl)carbamoyl]ethyl}-10-(1H-indol-3-ylmethylidene)-3-[2-(methylsulfanyl)ethyl]-1,4,5,8,11,14,18-heptaoxo-tetradecahydropyrrolo[1,2-n]1,4,7,10,14,17-hexaazacycloicosan-17-yl]benzamide
CAS Registry NumberNot Available
SMILES
CSCC[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CNC(=O)[C@@H](CCC(N)=O)NC(=O)\C(NC(=O)[C@@H](CCC(=O)NCCO)NC(=O)C1=O)=C\C1=CNC2=CC=CC=C12)NC(=O)C1=CC=CC=C1
InChI Identifier
InChI=1S/C44H54N10O11S/c1-66-21-17-29-37(58)43(64)51-31(14-16-36(57)46-18-20-55)40(61)52-32(22-26-23-47-28-11-6-5-10-27(26)28)41(62)50-30(13-15-35(45)56)39(60)48-24-33(53-38(59)25-8-3-2-4-9-25)44(65)54-19-7-12-34(54)42(63)49-29/h2-6,8-11,22-23,29-31,33-34,47,55H,7,12-21,24H2,1H3,(H2,45,56)(H,46,57)(H,48,60)(H,49,63)(H,50,62)(H,51,64)(H,52,61)(H,53,59)/b32-22-/t29-,30+,31+,33-,34-/m0/s1
InChI KeyXRQGNCFQZRALAT-UTYSYDMGSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
JahnellaNPAtlas
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP0.11ALOGPS
logP-2.6ChemAxon
logS-4.6ALOGPS
pKa (Strongest Acidic)11.45ChemAxon
pKa (Strongest Basic)-2.5ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count11ChemAxon
Hydrogen Donor Count10ChemAxon
Polar Surface Area320.19 ŲChemAxon
Rotatable Bond Count14ChemAxon
Refractivity240.91 m³·mol⁻¹ChemAxon
Polarizability95.49 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
NPAtlas IDNPA014195
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID78437964
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound139587038
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Plaza A, Viehrig K, Garcia R, Muller R: Jahnellamides, alpha-keto-beta-methionine-containing peptides from the terrestrial myxobacterium Jahnella sp.: structure and biosynthesis. Org Lett. 2013 Nov 15;15(22):5882-5. doi: 10.1021/ol402967y. Epub 2013 Nov 7. [PubMed:24199909 ]
  2. Mitchell PM: The cost-effectiveness of what in health and care?. 2021 Feb. [PubMed:34383398 ]
  3. Authors unspecified: Ozanimod. 2012. [PubMed:34383397 ]
  4. Authors unspecified: Ponesimod. 2012. [PubMed:34383396 ]
  5. Lee J, Cho Y, Choi KH, Hwang I, Oh YL: Metastatic leiomyosarcoma of the thyroid gland: cytologic findings and differential diagnosis. J Pathol Transl Med. 2021 Aug 13. pii: jptm.2021.06.23. doi: 10.4132/jptm.2021.06.23. [PubMed:34384147 ]
  6. Rossouw HM, Nagel SE, Pillay TS: Comparability of 11 different equations for estimating LDL cholesterol on different analysers. Clin Chem Lab Med. 2021 Aug 11. pii: cclm-2021-0747. doi: 10.1515/cclm-2021-0747. [PubMed:34384146 ]
  7. Winkel P, Hilden J, Jakobsen JC, Lindschou J, Jensen GB, Kjoller E, Sajadieh A, Kastrup J, Kolmos HJ, Larsson A, Arnlov J, Bjerre M, Gluud C: A screening method to spot biomarkers that may warn of serious events in a chronic disease - illustrated by cardiological CLARICOR trial data. Clin Chem Lab Med. 2021 Aug 12. pii: cclm-2021-0333. doi: 10.1515/cclm-2021-0333. [PubMed:34384145 ]
  8. Lombardi Y, Hiesse C, Ridel C, Touzot M: From combined heart-kidney to kidney transplantation program: what nephrologists should know about dilated cardiomyopathy. Transpl Int. 2021 Aug;34(8):1573-1575. doi: 10.1111/tri.13948. [PubMed:34384144 ]
  9. Kennedy LJ, Cukier S, Khoury L, Steeves D: 'You drink at home so they can go to work safely': A case study exploring alcohol marketing during the COVID-19 pandemic. Drug Alcohol Rev. 2021 Aug 12. doi: 10.1111/dar.13374. [PubMed:34384143 ]